98%
921
2 minutes
20
Breast lymphedema, an often-overlooked complication of breast cancer treatment, affects nearly half of patients undergoing breast conservation surgery and responds poorly to conservative measures. While lymphaticovenous bypass (LVB) is a well-established intervention for extremity lymphedema, its application in breast lymphedema has been sporadic. We utilized microsurgical robot system in 1 patient to overcome the technical challenges of performing LVB in the breast.A 42-year-old woman developed progressive right breast swelling, heaviness, and pain following lumpectomy, sentinel lymph node biopsy, chemotherapy, and radiotherapy. Conservative measures failed to provide relief. Indocyanine green lymphography (ICGL) revealed normal lymphatic drainage in the arm but dermal backflow in the central and lower breast. Linear patterns in the upper outer quadrant, terminating near the axillary scar, were marked. Using a microsurgical robotic system, 2 end-to-end LVBs were performed through a single skin incision. Immediate postoperative decongestion was observed, with sustained symptomatic improvement at 6 months, evidenced by reduced pain scores and a significant decrease in the Lymphedema Life Impact Score. A literature review identified 6 reports describing 7 cases of LVB for breast lymphedema. The number of bypasses per breast ranged from 1 to 6, with 1 or 2 skin incisions, predominantly in the upper outer quadrant. All cases reported prompt subjective symptom relief, though objective measures were inconsistently applied.Our case demonstrates the first successful application of robotic-assisted LVB for breast lymphedema with significant improvement in clinical signs and symptoms as well as quality of life, based on validated patient-reported outcomes. Robotic assistance enhanced both the feasibility and ergonomics of performing supermicrosurgical LVB in the anatomically complex breast region.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321348 | PMC |
http://dx.doi.org/10.1097/SAP.0000000000004364 | DOI Listing |
BMC Womens Health
August 2025
Department of Surgery, New York Medical College NYC Health and Hospitals-Metropolitan, 1901 1 st Ave, New York, NY, 10029, United States of America.
Background: Lymphedema is estimated to affect one in three breast cancer survivors longitudinally. Despite the high prevalence of secondary lymphedema amongst breast cancer survivors, it remains unrecognized and underdiagnosed by patients and physicians alike.
Case Presentation: A 56-year-old female with a three-year history of remission of breast cancer, status post bilateral total mastectomy with right axillary node dissection complicated by a seroma of the right chest wall and adjuvant chemotherapy and radiation, presented with a one-week history of worsening right upper extremity erythema, edema, and tenderness.
Medicina (Kaunas)
July 2025
Department of Medicine, Surgery and Dentistry, University of Salerno, 84081 Baronissi, Italy.
Breast cancer therapy is a common cause of lymphedema. The accumulation of protein-rich fluid in the affected extremity leads to a progressive path-swelling, inflammation, and fibrosis-namely, irreversible changes. A scientific literature analysis was performed on PubMed/Medline, Scopus, Web of Science (WoS), the Cochrane Central Register of Controlled Trials (CENTRAL), and the Physiotherapy Evidence Database (PEDro) from inception until 30 June 2024.
View Article and Find Full Text PDFBiomedicines
August 2025
Department of Physical Therapy, Health Sciences Center, Federal University of Pernambuco, Recife 50670-901, Brazil.
: Breast cancer is the most common neoplasm in women. Despite effective treatments, sequelae such as decreased muscle strength, upper limb dysfunction, and tissue changes are common, highlighting the need for functional assessments during rehabilitation. This study analysed the morphofunctional profile of the upper limbs in breast cancer survivors, comparing muscle strength and ultrasound findings between groups with and without lymphoedema, as well as between ipsilateral and contralateral limbs.
View Article and Find Full Text PDFJ Formos Med Assoc
August 2025
Division of General Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical University, Taipei, 114, Taiwan. Electronic address:
Background: Breast cancer is the most common cancer worldwide and ranks as the leading type among women in Taiwan. Traditionally, axillary lymph node dissection (ALND) has been the standard for early-stage breast cancer; however, for cases without lymph node involvement, particularly small tumors, this procedure may offer limited benefit and could lead to severe complications such as arm lymph-edema.
Objective: This study aimed to assess the accuracy of ultrasound, mammography, and MRI in preoperative prediction of axillary lymph node status in early-stage breast cancer patients, with the goal of reducing unnecessary ALND.
Plast Reconstr Surg
August 2025
Department of Infectious Diseases, Infection Control and Employee Health.
Background: Poorly managed breast cancer-related lymphedema (BCRL) may lead to recurrent cellulitis. Advances in the management of lymphedema have evolved beyond conservative decongestive therapy to include vascularized lymph node transfer (VLNT). Herein, we analyzed the impact of VLNT in the reduction of upper extremity cellulitis in breast cancer survivors.
View Article and Find Full Text PDF